Form 8-K - Current report:
SEC Accession No. 0001169245-21-000076
Filing Date
2021-08-12
Accepted
2021-08-12 10:11:38
Documents
41
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kx81221.htm 8-K 29327
2 EX-99.1 phasebio_q22021financialsd.htm EX-99.1 72100
3 EX-99.2 phasebiocorporateovervie.htm EX-99.2 48148
4 EX-99.3 phasebiointerimanalysisenr.htm EX-99.3 20337
5 image_0.jpg GRAPHIC 914863
6 image_01.jpg GRAPHIC 914863
7 image_1.jpg GRAPHIC 69
8 GRAPHIC phasebiocorporateovervie001.jpg GRAPHIC 67124
9 GRAPHIC phasebiocorporateovervie002.jpg GRAPHIC 190147
10 GRAPHIC phasebiocorporateovervie003.jpg GRAPHIC 145230
11 GRAPHIC phasebiocorporateovervie004.jpg GRAPHIC 113030
12 GRAPHIC phasebiocorporateovervie005.jpg GRAPHIC 35457
13 GRAPHIC phasebiocorporateovervie006.jpg GRAPHIC 128626
14 GRAPHIC phasebiocorporateovervie007.jpg GRAPHIC 109538
15 GRAPHIC phasebiocorporateovervie008.jpg GRAPHIC 86306
16 GRAPHIC phasebiocorporateovervie009.jpg GRAPHIC 47376
17 GRAPHIC phasebiocorporateovervie010.jpg GRAPHIC 141039
18 GRAPHIC phasebiocorporateovervie011.jpg GRAPHIC 96981
19 GRAPHIC phasebiocorporateovervie012.jpg GRAPHIC 123188
20 GRAPHIC phasebiocorporateovervie013.jpg GRAPHIC 112485
21 GRAPHIC phasebiocorporateovervie014.jpg GRAPHIC 127804
22 GRAPHIC phasebiocorporateovervie015.jpg GRAPHIC 152272
23 GRAPHIC phasebiocorporateovervie016.jpg GRAPHIC 133884
24 GRAPHIC phasebiocorporateovervie017.jpg GRAPHIC 120367
25 GRAPHIC phasebiocorporateovervie018.jpg GRAPHIC 132555
26 GRAPHIC phasebiocorporateovervie019.jpg GRAPHIC 149151
27 GRAPHIC phasebiocorporateovervie020.jpg GRAPHIC 136649
28 GRAPHIC phasebiocorporateovervie021.jpg GRAPHIC 154990
29 GRAPHIC phasebiocorporateovervie022.jpg GRAPHIC 136607
30 GRAPHIC phasebiocorporateovervie023.jpg GRAPHIC 104634
31 GRAPHIC phasebiocorporateovervie024.jpg GRAPHIC 109335
32 GRAPHIC phasebiocorporateovervie025.jpg GRAPHIC 102857
33 GRAPHIC phasebiocorporateovervie026.jpg GRAPHIC 58755
34 GRAPHIC phasebiocorporateovervie027.jpg GRAPHIC 96173
35 GRAPHIC phasebiocorporateovervie028.jpg GRAPHIC 112871
36 GRAPHIC phasebiocorporateovervie029.jpg GRAPHIC 112873
37 GRAPHIC phasebiocorporateovervie030.jpg GRAPHIC 120256
38 GRAPHIC phasebiocorporateovervie031.jpg GRAPHIC 51017
39 GRAPHIC phasebiocorporateovervie032.jpg GRAPHIC 145335
40 GRAPHIC phasebiocorporateovervie033.jpg GRAPHIC 123343
41 GRAPHIC phasebiocorporateovervie034.jpg GRAPHIC 59935
  Complete submission text file 0001169245-21-000076.txt   7895498
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 211165836
SIC: 2834 Pharmaceutical Preparations